House of Commons photo

Crucial Fact

  • His favourite word was senate.

Last in Parliament October 2015, as Conservative MP for Charleswood—St. James—Assiniboia (Manitoba)

Lost his last election, in 2015, with 39% of the vote.

Statements in the House

Business of Supply May 16th, 2006

Mr. Speaker, I am pleased to address the motion of the hon. member for Toronto--Danforth.

One thing that struck me when I read this motion was that while the House may want to express an opinion on this, the proposal would likely have the federal government trespassing in areas of provincial jurisdiction. Let me take a moment to provide this insight for the House.

Section 92.13 of the Constitution says that provinces have jurisdiction over property and civil rights within their boundaries. It seems to me that many of the actions anticipated here are covered. Under section 92.8, the provinces have jurisdiction over municipal institutions and some municipalities have chosen to act in this area.

Constitutional issues aside, this motion appears to ignore the efforts that are made in Canada to ensure that the pesticide products legally in use in Canada are those that are safe to use according to the best possible scientific evidence. It also ignores the state of the law on pesticides or pest control products, and it ignores the efforts being made to ensure that risks to human health and to the environment are minimized when those products are used according to directions.

Without question, the regulatory environment in which the Government of Canada in general and the health portfolio in particular are functioning is a challenging one. There is the sheer scope of the enterprise. In all, Health Canada, the Public Health Agency and the Pest Management Regulatory Agency are responsible for 14 regulatory programs, often working in collaboration with partners in the provinces and territories and other stakeholders.

The regulatory responsibilities dealt with in this portfolio touch the lives of Canadians in many ways, including food, drugs, medical devices, natural health products, hazardous materials, consumer products, assisted human reproduction, and of course our topic today, pesticides. In short, the health portfolio and the department and agencies therein engage in a complicated juggling act, but the fact is that they work together to protect and promote the health of Canadians and to offer timely access to safe and effective therapies and products.

In speaking to the motion brought forth today, I want to comment on the Pest Control Products Act, legislation for which the hon. Minister of Health is responsible to Parliament. I also want to describe the work of Health Canada's Pest Management Regulatory Agency, the PMRA, which is the regulatory body overseeing pesticides in this country. In particular, I want to comment on new pesticide legislation that our government looks forward to seeing in force soon.

Let me underline a few key points about pesticides and their regulation in Canada.

The most important point is this. The regulation and overseeing of pesticides by Health Canada under Canadian law is exacting. It is driven by the best and newest scientific evidence available and it is aimed squarely at this goal: to ensure that the only pesticides that are registered or permitted for use in this country are products that pose no unacceptable risks to health or to the environment of Canadians.

There can be risks associated with the use of pesticides. For this reason, pesticides are among the most rigorously tested and regulated substances in the world. What does that mean in practice? It means that any company that wants to introduce a pesticide into the Canadian market has to seek and obtain the approval of Health Canada, and any such company must do so on the basis of scientific evidence that shows that health and environmental risks are within acceptable limits.

Several of my colleagues have already commented on the excellent work and the rigorous processes of Health Canada and the Pest Management Regulatory Agency in detail, but let me say this much. The process of determining whether to register a pesticide for sale and use in Canada is guided by the best science possible.

The analysis of the evidence the PMRA scientists conduct is a careful one. The work of that agency is seen as among the most stringent in the world and work that regulatory partners in other countries treat with respect.

Let me offer one example of how stringent that analysis is. The scientific testing required prior to registration has to address the potential impacts of pesticide on Canadians of all ages, from our youngest to our oldest. There is no one size fits all approach to evaluating products as important as these.

More than that, the PMRA continually updates its pesticide assessment methods to draw on the latest and best evidence to meet our goal of ensuring the utmost safety for Canadians and Canada's environment. As part of this, the PMRA conducts special reviews or re-evaluations of existing registered products.

Those reviews and re-evaluations enable the PMRA scientists to evaluate new safety issues, bring assessments of old products up to modern safety standards and amend the registration status of a product when the evidence shows that is necessary.

All this is taking place under an act that dates back to 1969. We soon expect to bring into force the new Pest Control Products Act, along with the many regulations and procedures that have had to be consulted on and developed to support the new legislation.

The new act is the result of substantial efforts over many year to reflect the kind of pesticide regulatory system that Canadians expect and deserve, one that earns their confidence.

Let me remind the House about the act. The new Pest Control Products Act does not change the fundamental way in which pesticides are regulated in Canada, which I described a few moments ago. However the new act achieves three goals.

First, it strengthens the health and environmental protection provided under existing law. For example, a number of definitions have been included for important terms, such as “health risk”, “environmental risk” and “value”. The term “environment” is defined in the same way as it is in the Canadian Environmental Protection Act.

The new act includes an interpretation of the term “acceptable risk”. It states that the health and environmental risk of a pest control product are acceptable if there is reasonable certainty that no harm to human health, future generations or the environment will result when the product is used as directed.

Current PMRA risk assessment and risk management practices are consistent with this definition. this enshrines that approach in law. Let me offer the House an example.

A minute or two ago I mentioned that Health Canada evaluates products for their impacts on people of all ages and the new legislation requires that. However it also requires that an additional margin of safety must be applied to protect infants and children from risks posed by pesticide residues in food and when pesticides are used in and around homes and schools.

The second accomplishment of the new act is to make the registration for pesticides more transparent. Canadians want to know about the substances being used in their environment. The new act introduces broad access to information provisions. Essentially, with two exceptions, all information related to a product and its registration will now be publicly available once the law is fully in force. The first exception is confidential test data that is normally scientific information. Now will that be hidden from view? No.

Even that confidential test data will be available for public examination in a reading room after a pesticide is registered. In fact, only confidential business information that meets a very precise and narrow definition, such as financial information, manufacturing processes and ingredients in a product that are not of health or environmental concern, will remain confidential.

On the other hand, the identity and concentration of ingredients or formulants that are of health or environmental concern will be made available to the public on labels and material safety data sheets and through the public registry.

The openness of the new act is shown in other ways as well. The new act will require public consultation before a major registration decision is made final. As a part of this, Canadians and all interested parties, including other levels of government, will be able to see summaries of the evaluation of pesticide risks and values, along with the proposed decision and rationale.

Under the new act, any member of the public can file a notice of objection to a major registration decision. The new legislation brings a much greater level of accountability than the previous legislation.

The importance of this kind of accountability and transparency transcends the issue of pesticide regulation. Our government takes accountability very seriously and made it one of its highest priorities. Canadians have a desire and the right to see how the health regulatory process works and to know how the government is working for them.

The new act delivers a third achievement, which is to strengthen the control on pesticides after they have been registered. In particular, the new act strengthens the existing provisions for re-evaluations or special reviews of pest control products.

I want to point out one aspect of these new provisions that is relevant to this debate. I know we have heard and will hear about the precautionary principle in connection with the use of pesticides. The new act incorporates that principle.

If there is reason to believe that a registered pesticide is posing a threat of serious or irreversible damage, the Minister of Health can implement cost effective measures to prevent adverse health impacts or environmental degradation. That would be true even if the evidence falls short of full scientific certainty at the time.

Let me mention one more aspect of the new act. It requires the reporting of new information that indicates the health or environmental risks or the value of a registered pesticide may no longer be acceptable. That could be evidence of adverse impacts to human or environmental health. It could be new scientific evidence.

In all these and other ways, the new legislation raises the bar in terms of accountability and transparency, all grounded in the best science possible.

I want to make an important remark about the new act that I believe is no less important. The new act does not see products such as pesticides as the be all and end all of dealing with pests. In fact, the new act encourages sustainable pest management and will help us improve access to pesticides with even lower risks, to meet the demand that is clearly growing among many Canadians.

It recognizes that wise pesticide use includes room for no pesticide use or the use of alternative methods. Quite simply, it enables people to make choices that are supported by science. The approach that we have in Canada to the regulation of pesticides is known and respected around the world.

Before I end my comments today, I want to make one last point about Canada's international efforts.

Canada participates actively with both NAFTA partners, the U.S. and Mexico, as well as members of the Organisation of Economic Cooperation and Development, to ensure that standards for pesticides incorporate the latest scientific knowledge.

Canada works jointly with its U.S. counterpart, the Environmental Protection Agency, to re-evaluate older pesticides to ensure they meet modern standards. The U.S. budget for re-evaluations is $58 million U.S., while Health Canada currently budgets $10 million. By using U.S. reviews and leveraging work completed by the U.S., Health Canada's Pest Management Regulatory Agency is able to re-evaluate older pesticides registered in Canada to ensure they meet modern safety standards in as short a time as possible.

I thank the hon. member for Toronto--Danforth for the motion presented today but the system that we have works well. It is a system that is constantly improving and, as new evidence comes to light, we will see a new system blossom under the new act. Above all, it is a system that is driven by firm commitment to act in ways that respect human health and the health of our environment. As we implement the new Pest Control Products Act, Canadians will see the commitment even more clearly.

Budget Implementation Act, 2006 May 15th, 2006

Mr. Speaker, the government obviously agrees that more needs to be done for Canadians who are disadvantaged. That is why over 600,000 Canadians are going to be removed from the tax rolls in this budget.

I think the member would agree that there are some honest disagreements and philosophies between the two governments. This government was elected on certain principles and promises and, in fact, this budget fulfills those promises. One of those promises was to deal with pandemics. This budget puts $1 billion toward pandemic preparedness. As the member knows, the virology lab is in Winnipeg, a city that the member and I share.

There is also a substantial investment in cancer control. There is $260 million for the Canadian Strategy for Cancer Control, a motion that the NDP supported in the last Parliament and the previous government refused to fully fund and implement.

I wonder if the member would agree that the investments in pandemics and cancer control are good investments and something the previous government refused to do. Or, is the member's party changing its position on the Canadian Strategy for Cancer Control and pandemic preparedness?

Hypertension May 11th, 2006

Mr. Speaker, I am pleased to inform the House that Saturday, May 13 is World Hypertension Day.

The purpose of World Hypertension Day is to communicate to the public the importance of hypertension and its serious medical complications and to provide information on prevention, detection and treatment.

Hypertension, or high blood pressure, is a major risk factor for cardiovascular disease and stroke.

Approximately one in five adult Canadians has hypertension. However, many people are undiagnosed and are unaware that they are at risk. This is why high blood pressure is sometimes referred to as the silent killer.

Health care professionals, volunteer organizations, the private sector and government are working together to improve awareness of hypertension in Canada.

Our government is committed to making progress on heart disease and hypertension.

I am pleased to join in the spreading of the simple message to encourage Canadians to have their blood pressure checked and to make sure that they take time to learn more about the condition. I invite members of the House to do the same.

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, early in his comments the member touched on what the Bloc member had to say. I would just like to get the member's view on the importance of working as a nation in the area of public health, while ensuring that we do not intrude into any areas that the federal government has no power, to ensure that people throughout Canada, including Quebeckers, have the access to public health that they deserve. The member may want to talk about the virology lab which is an excellent example of where the nation's resources were pooled together to create a better good for everyone within the nation.

I wonder if the member could discuss the importance of working together as a people in the area of public health.

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, part of being a nation is ensuring that all its citizens have security, good order, good government, peace and good public health. This is a machinery bill that will allow the Government of Canada to do that. In fact, there is no change in power or jurisdictional issues. This is all within the powers that already exist with the federal government.

The member talked about jurisdictional issues. There is an explicit federal rule in controlling infectious diseases at our borders, something with which the Chief Public Health Officer would deal. There is no expansion in any way, shape or form of the federal role in provincial jurisdictions.

The member talks about an independent Quebec. However, there are synergies in working with all Canadians. Another example of that is the virology lab in Winnipeg. The virology lab provides many services for people across Canada, including Quebeckers. If we carry the member's logic to its natural conclusion, he would expect each province to have its own lab, which is hugely expensive, and there are not enough human resources to staff such labs.

Would the member admit that synergies are to be gained by working together and that all Canadians, including Canadians who live in Quebec, benefit from having a coordinated and deliberate strategy?

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, the member talked about jurisdiction. In fact, public health is a shared jurisdiction. We are not talking about the direct delivery of health care in hospitals or otherwise.

I wonder if the member could comment on the virology lab in Winnipeg. If the member believes that each province can do everything completely independently, then he must believe that each province should have its own virology lab. I ask the member where he will get the expertise, moneys and other support in order to do that. If he does not believe that, then he must believe that there is a shared responsibility on behalf of everyone in the Canadian federation to work together to protect the public from pandemics and deadly diseases.

I assume the member therefore needs to change his position and support this public health act, because there are synergies that can be gained by working together as Canadians.

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, to clarify for the NDP member, actually the 2006 budget provides for $450 million to improve water and housing for on reserve educational outcomes and to assist aboriginal women and children. The budget also firms up to $600 million for aboriginal housing off reserve and in the north.

With regard to my question for the member for Burlington, we have heard a lot of rhetoric from the Liberals, but here we are within 100 days of our party forming the government and we have brought forward Bill C-5 and the Liberals were not even able to bring it to a vote. I wonder if the member could comment on the contrast between the previous government and this government's commitment to public health.

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, the member pointed out that the virology lab in Winnipeg is in his riding. We have heard from the Bloc Québécois that Quebec is independent and that the Quebec public health agency does not need help from the rest of Canada.

The member mentioned that the virology lab is the only level four lab in the country. I wonder if the member would agree that the virology lab is an excellent example of many of why we need a national collaboration in dealing with public health.

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, this agency has been in existence through order in council for many years. There has been no legislative framework or legislative authority, which makes one wonder about the previous government's commitment to public health. The bill did not even make it to a vote under the previous government.

Would the member comment on the Conservative government's commitment to public health and the fact that the bill was introduced in the first 100 days of being in office, versus the previous government that did not even get the bill to a vote during its 13 years in office?

Public Health Agency of Canada Act May 5th, 2006

Mr. Speaker, I found it interesting that before the budget the NDP raised concerns about the moneys that would be provided to deal with a pandemic. I trust since the issue was not raised post-budget by the NDP that this concern has been alleviated with the $1 billion committed in this budget to deal with pandemic issues. Incidentally, the Minister of Health will also be leading a provincial-territorial conference next week on pandemic preparedness.

My question for the member is twofold. I realize the member was on the health committee in the last session. First, I wonder if the member would comment on the fact that under the previous government it seemed that the bill did not get the attention it deserved. In fact, it never even came to a vote, whereas under this government the bill has been brought forward within the first 100 days. That certainly suggests quite a difference between the commitment of this government to public health and the commitment of the previous government, with our government being very keen on pursuing the matter whereas the other government seemed to delay. I would be interested in the member's comments on the previous government's commitment, or lack thereof, to public health.

The second question I have for the member deals with the Bloc's comments with regard to jurisdictional issues. The Bloc seemed to try to make the case that pandemics will respect provincial and other boundaries, whereas I think most reasonable people would agree that pandemics and other diseases do not respect boundaries and it is very important to have a public health agency in order to have a meaningful, deliberate and comprehensive strategy to deal with the challenges that may exist when dealing with a pandemic. A national agency would help do that.

Would the member comment on those two issues?